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Abstract
Protein phosphorylation by kinases and the subsequent dephosphorylation by phosphatases are key
mechanisms that regulate intracellular signal transduction during development. Here, we report the
identification of the receptor protein tyrosine phosphatase DEP-1 as a negative regulator of the
Caenorhabditis elegans EGF receptor. DEP-1 amplifies in the developing vulva and the excretory
system the small differences in the amount of EGF signal received by equivalent precursor cells to
achieve binary cell fate decisions. During vulval development, DEP-1 inhibits EGFR signaling in the
secondary cell lineage in parallel with the NOTCH-mediated lateral inhibition, while EGFR signaling
simultaneously down-regulates DEP-1 and NOTCH expression in the primary cell lineage. This
regulatory network of inhibitors results in the full activation of the EGFR/RAS/MAPK pathway in the
primary vulval cells and at the same time keeps the EGFR/RAS/MAPK pathway inactive in the adjacent
secondary cells. Mammalian Dep-1/Scc1 functions as a tumor-suppressor gene in the intestinal
epithelium. Thus, mutations in human Dep-1 may promote tumor formation through a hyperactivation
of the EGF receptor.
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Abstract
Protein phosphorylation by kinases and the subsequent
dephosphorylation by phosphatases are key mechanisms that regulate
intracellular signal transduction during development. Despite the large number
of phosphatases encoded by animal genomes, relatively little is known about
their specific functions during development. Furthermore, only a few
physiological substrates of protein phosphatases have been identified.
Here, we report the identification of the receptor protein tyrosine
phosphatase DEP-1 as a negative regulator of the C. elegans EGF receptor.
DEP-1 amplifies in the developing vulva and the excretory system the small
differences in the amount of EGF signal received by equivalent precursor cells
to achieve binary cell fate decisions. In the vulva, DEP-1 inhibits EGFR
signaling in the secondary cell lineage in parallel with the NOTCH-mediated
lateral inhibition, while EGFR signaling simultaneously down-regulates DEP-1
and NOTCH expression in the primary cell lineage. This regulatory network of
inhibitors results in the full activation of the EGFR/RAS/MAPK pathway in the
primary vulval cells and at the same time keeps the EGFR/RAS/MAPK pathway
inactive in the adjacent secondary cells. Mammalian Dep-1/Scc1 functions as a
tumor suppressor gene in the intestinal epithelium. Thus, mutations in Dep-1
may promote tumor formation due to a hyperactivation of the EGF receptor.
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Introduction
Several components of the EGF receptor signal transduction pathway are
phosphorylated when an EGF ligand binds to its receptor (for review see
Schlessinger 2000). In particular, autophosphorylation of the EGFR at specific
intracellular tyrosine residues is critical for the subsequent signal transduction. Protein
phosphatases may be part of a negative regulatory network that attenuates the
activity of the EGFR/RAS/MAPK pathway. The genomes of both invertebrates and
vertebrates encode a large number of predicted phosphatases genes (Bhaduri and
Sowdhamini 2003; Alonso et al. 2004). For example, the C. elegans genome contains
at least 165 putative protein phosphatase genes (www.wormbase.org). However, the
physiological substrates of most protein phosphatases have not yet been identified,
as many experiments addressing this question were performed in vitro by
overexpression, which impairs the substrate specificity of phosphatases (den Hertog
1999). Only a few protein phosphatases have been assigned specific roles in
developmental processes or signaling pathways through clear-cut loss-of-function
genetics. Examples include the mouse PTP 1B that inhibits insulin receptor signaling
(Elchebly et al. 1999), Drosophila PTP-ER, which inhibits MAPK signaling during eye
development (Karim and Rubin 1999) and C. elegans CLR-1, which inactivates the
EGL-15 FGF receptor (Kokel et al. 1998). However, in many cases the identification
and functional analysis of phosphatases is complicated by the fact that animals
mutant for a single phosphatase gene display no obvious phenotype, suggesting that
most protein phosphatases act redundantly with other modifiers (Harroch et al. 2000;
Haj et al. 2003).
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Mammalian Dep1  is a member of the class III Receptor Protein Tyrosine
Phosphatase (R-PTP) family (den Hertog 1999). Dep-1 expression is induced in
contact-inhibited cell cultures, hence the name Density-enhanced phosphatase 1
(Ostman et al. 1994). Different receptor tyrosine kinases (RTKs) including c-Met,
PDGFR and VEGFR-2 are Dep-1 substrates in vitro, but whether these RTKs are
also in vivo substrates of Dep-1 is not known (Lampugnani et al. 2003; Jandt et al.
2003; Palka et al. 2003). Interestingly, Dep-1 exhibits tumor suppressor activity when
overexpressed in cultured tumor cells (Keane et al. 1996; Trapasso et al. 2000), and
the mouse Dep-1 gene was recently identified as the colon cancer susceptibility locus
scc1 (Ruivenkamp et al. 2002). Human Dep-1 is often mutated in colon, breast, skin
and lung carcinomas (Ruivenkamp et al. 2002). Despite its importance as tumor
suppressor in various epithelial tissues, the biological functions of Dep-1 are not
understood. Numerous questions remain to be answered to elucidate the role of Dep-
1 in tumorigenesis, including the identification of physiological substrates and the role
of Dep-1 in cell fate specification and pattern formation during normal development.
The development of the C. elegans hermaphrodite vulva serves as a paradigm
to study how equivalent precursor cells can integrate the input from multiple signaling
pathways to achieve a binary cell fate decision (Sundaram 2004). During vulval
induction, the anchor cell (AC) in the somatic gonad secretes the EGF-like growth
factor LIN-3 to activate the EGFR/RAS/MAPK pathway in the adjacent vulval
precursor cells (VPCs). The strength of the EGFR/RAS/MAPK signal in the VPCs
depends on their distance from the AC (Yoo et al. 2004). The VPC located closest to
the AC, P6.p, exhibits highest RAS/MAPK activity and adopts the primary (1°) cell
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fate. The neighboring VPCs, P5.p and P7.p, exhibit intermediate levels of RAS/MAPK
activity (Yoo et al. 2004), and the distal VPCs P3.p, P4.p and P8.p that are further
away from the AC display weak RAS/MAPK activity due to a relay signal generated
by the proximal VPCs (Dutt et al. 2004). However, by the time of vulval cell fate
specification at the beginning of the L3 stage, a lateral signal from P6.p that is
transduced by the DELTA/NOTCH signaling pathway inactivates the
EGFR/RAS/MAPK pathway in P5.p and P7.p to prevent 1° cell fate specification and
induce the secondary (2°) fate in these cells (Ambros 1999; Berset et al. 2001; Chen
and Greenwald 2004; Yoo et al. 2004). LIN-12 NOTCH signaling inhibits 1° fate
specification in P5.p and P7.p by up-regulating the transcription of several negative
regulators of the EGFR/RAS/MAPK signaling pathway such as lip-1, dpy-23 and the
lst genes (Berset et al. 2001; Yoo et al. 2004). In particular, the dual-specificity
phosphatase LIP-1, which is the homologue of vertebrate MKP-3, inactivates the
MAP kinase MPK-1 to inhibit 1° fate specification in P5.p and P7.p (Berset et al.
2001). However, lip-1(lf) or lst RNA interference (RNAi) animals develop a
morphologically wild-type vulva. Moreover, double mutants between lip-1(lf) and
known inhibitors of the EGFR/RAS/MAPK signaling pathway such as unc-101 (Lee et
al. 1994), sli-1 (Yoon et al. 1995), gap-1 (Hajnal et al. 1997) or ark-1 (Hopper et al.
2000) display no visible defects in lateral inhibition (T. Berset and A. Hajnal,
unpublished results). These observations suggested that lip-1 and the lst genes act
redundantly with other inhibitors of the EGFR/RAS/MAPK pathway to achieve the
binary, 1° versus 2° cell fate decision in the VPCs.
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Here, we report the identification of the C. elegans R-PTP dep-1 in a genetic
screen for genes that regulate the 1° versus 2° cell fate decision during vulval
development. DEP-1 negatively regulates LET-23 EGFR signaling in the vulva and
the excretory system in parallel with the MAPK phosphatases LIP-1 and
independently of LIN-12 NOTCH. Similar to mutations in the mammalian Dep-1/Scc1
tumor suppressor gene, which alone are not sufficient to induce tumor formation
(Ruivenkamp et al. 2002), the developmental phenotypes of dep-1 only manifest in
sensitized genetic backgrounds. Therefore, C. elegans vulval development serves as
a genetic model to identify the homologs of mammalian tumor suppressor genes and
study their genetic interactions with conserved signaling pathways.
Results
A genetic screen for adjacent primary cell fate mutants
To identify new genes that regulate the 1° versus 2° vulval cell fate decision in
parallel with lip-1, we screened approximately 30’000 haploid genomes in a lip-1(lf)
background for synthetic Adjacent primary cell fate (Apf) mutants using morphological
criteria to identify animals with 2° to 1° cell fate transformations (Fig.1 A) .
Descendants of 1° vulval cells detach from the cuticula and migrate inwards (Katz et
al. 1995). In this way, we isolated a loss-of-function mutation (zh34) in a previously
uncharacterized gene that we named dep-1 (see below). dep-1(lf); lip-1(lf) double
mutants display a strong Apf and weak multivulva (Muv) phenotype, while dep-1(lf) or
lip-1(lf) single mutants develop a wild-type vulva (Fig.1 B to E, Tab. 1). A similar Apf
nonMuv phenotype can by observed if the EGFR/RAS/MAPK pathway is
Berset et al. C. elegans DEP-1 inhibits EGFR signaling
7
hyperactivated after the first round of vulval cell divisions has occurred by
overexpressing MPK-1 under the control of a heat shock-inducible promoter (Fig. 1 F
and G, Tab.1) (Lackner and Kim 1998; Wang and Sternberg 1999). Thus, prolonged
MAPK signaling causes a similar 2° to 1° cell fate transformation as observed in dep-
1(lf); lip-1(lf) double mutants. To further test whether dep-1 prevents 1° cell fate
specification in adjacent VPCs, we removed dep-1 function in sensitized genetic
backgrounds exhibiting elevated EGFR/RAS/MAPK signaling. A gain-of-function
mutation in the let-60 ras gene or a reduction-of-function mutation in lin-15 causes a
strong Muv phenotype, but loss of dep-1 function additionally results in an Apf
phenotype (Fig. 1 H to K and Tab.1). In addition, we used the egl-17::cfp reporter as a
molecular marker for the 1° cell fate (Burdine et al. 1998; Yoo et al. 2004). In a wild-
type background, dep-1(lf) does not cause ectopic egl-17::cfp expression, but in a let-
60(gf) background dep-1(lf) increases the number of adjacent cells expressing egl-
17::cfp (Fig. 1 N). On the other hand, loss of dep-1 function does not significantly alter
egl-17::cfp expression in a lip-1(lf) background (Fig. 1 N). Since egl-17::cfp
expression does not always correlate with the vulval morphology, we tested LET-23
EGFR expression as another 1° cell fate marker (Kaech et al. 1998). In wild-type L3
larvae, LET-23 EGFR is strongly expressed in the 1° descendants of P6.p but is
down-regulated in the 2° descendants of P5.p and P7.p. Ectopic LET-23 EGFR
expression in 2° cells is rarely observed in lip-1(lf) or dep-1(lf) single mutants, but in
51% of dep-1(lf); lip-1(lf) double mutants LET-23 EGFR persists in 2° cells (Fig. 1 O
and P). Thus, the morphological and molecular characterization of the cell fates in
dep-1(lf); lip-1(lf) double mutants suggests that the Apf phenotype is due to prolonged
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EGFR/RAS/MAPK signaling in P5.p and P7.p, which causes a 2° to 1° cell fate
transformation.
dep-1 acts downstream of or in parallel with LIN-12 NOTCH
To examine the genetic interaction between dep-1 and the lin-12 notch pathway,
we tested whether dep-1(lf) affects 2° fate specification in a lin-12 notch(gf)
background, in which all six VPCs adopt the 2° cell fate (Greenwald et al. 1983). In
dep-1(lf); lin-12(gf) or lin-12(gf); lip-1(lf) double mutants, all VPCs adopt the 2° fate
(n=23 and n=22, respectively), but 74% of dep-1(lf); lin-12(gf); lip-1(lf) triple mutants
are Apf (Fig.1 L and M, n=23). Since lin-12(gf) animals have no AC, the somatic
gonad in these animals produces no inductive LIN-3 EGF signal that could activate
the LET-23 EGFR (Greenwald et al. 1983). However, gonad ablations demonstrated
that vulval induction in dep-1(lf); lip-1(lf) animals can occur independently of the AC
signal (Tab. 1). Thus, DEP-1 acts downstream of or in parallel with LIN-12 NOTCH to
inhibit 1° fate specification.
dep-1 encodes a receptor protein tyrosine phosphatase
We identified F44G4.8 as the dep-1 locus by positional cloning (Fig. 2 A and
materials and methods). dep-1 encodes a protein of 1367 amino acids that exhibits
strongest sequence similarity to the class III R-PTPs, which include the human
Density-enhanced phosphatase-1 (DEP-1) (Ostman et al. 1994), R-PTP-H (Marneros
et al. 2001) and R-PTPBeta (Fig. 2 B and C) (Kaplan et al. 1990) as well as Drosophila
Ptp4E and PTP10D (Yang et al. 1991). dep-1 encodes the only C. elegans
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phosphatase that contains the domain arrangement characteristic of the class III R-
PTPs, as defined by the presence of a single intracellular catalytic tyrosine
phosphatases domain, a transmembrane domain and multiple extracellular fibronectin
type III repeats (den Hertog 1999). Since mammalian DEP-1 is the best-characterized
member of this R-PTP family, we named the C. elegans F44G4.8 gene dep-1.
C. elegans dep-1(zh34) animals carry a stop mutation at position 1162, truncating
the protein before the catalytic center of the phosphatase domain (Fig 2. B and D).
Since this mutation is predicted to destroy the catalytic phosphatase activity, zh34
likely represents a loss- or strong reduction-of-function allele (dep-1(lf)). Supporting
these observations, RNAi against dep-1 in a lip-1(lf) background induces a penetrant
Apf phenotype, and a genomic DNA fragment that spans the dep-1 locus rescues the
Apf phenotype of dep-1(lf); lip-1(lf) animals (Fig. 2 A and Tab. 1).
DEP-1 inhibits LET-23 EGFR signaling
Next, we tested whether dep-1 negatively regulates the activity of the LET-23
EGFR during vulval induction. dep-1(lf) suppresses the vulvaless (Vul) phenotype
caused by lin-7, lin-2 or lin-10 mutations, which reduce but do not eliminate the
activity of let-23 egfr (Kaech et al. 1998).. Furthermore, dep-1 RNAi suppresses the
let-23 egfr(sy1) reduction-of-function mutation (Tab. 1). (Since dep-1 maps within less
than 0.1 map units of let-23 we were unable to generate dep-1; let-23 double
mutants.) In contrast, a sem-5 grb2(rf) mutation, which blocks signal transduction
downstream of let-23 egfr (Clark et al. 1992), is not suppressed by dep-1(lf) (Tab. 1).
Since wnt  signaling promotes vulval cell fate specification in parallel to the
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EGFR/RAS/MAPK pathway we examined the interaction of dep-1 with wnt pathway
mutants (Gleason et al. 2002). A mutation in the ß-catenin bar-1 is not suppressed by
dep-1(lf), indicating that DEP-1 does not act downstream of BAR-1. Furthermore, a
mutation in the negative regulator of the wnt pathway pry-1 axin (Korswagen et al.
2002) causes a Muv phenotype but no ectopic egl-17::cfp expression (Fig. 1 N).
Confirming the results of the epistasis analysis, we observed a physical interaction
between DEP-1 and LET-23 EGFR in GST pull-down experiments (Fig. 3). LET-23
EGFR from whole animal extracts specifically bound to the intracellular domain of
DEP-1 carrying a substrate-trapping mutation in the phosphatase domain (GST::DEP-
1D1241A) that allows the catalytically inactive enzyme to remain bound to its
phosphorylated substrate (Palka et al. 2003). On the other hand, neither wild-type
DEP-1 (GST::DEP-1wt) nor GST alone bound to LET-23 EGFR. Taken together,
these results indicate that DEP-1 inhibits inductive AC signaling by dephosphorylating
LET-23 EGFR.
DEP-1::GFP is expressed in 2° vulval cells independently of the lateral LIN-12
NOTCH signal
To investigate the dep-1 expression pattern, we generated a transcriptional dep-
1p::gfp and a rescuing translational DEP-1::GFP reporter line (Fig. 2 A and Tab.1).
Both reporters are expressed at the time of vulval induction at equal levels in P5.p,
P6.p and P7.p (Fig. 4 A). After the first round of cell divisions, the translational DEP-
1::GFP reporter is down-regulated in the 1° lineage, but expression persists in the 2°
vulval cells until the L4 stage (Fig. 4 B to F; DEP-1::GFP expression is lower in P6.p
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than in P5.p or P7.p descendants in 82% of L3 and in 95% of L4 larvae, n=61 and
n=21, respectively). A similar reduction of the expression in the 1° lineage is observed
with the transcriptional reporter (Fig. 4 G, dep-1p::gfp expression is lower in P6.p than
in P5.p or P7.p descendants in 80% of the L3 larvae, n=78). In most cases (e.g. 17
out of 18 larvae at the Pn.px and Pn.pxx stages), DEP-1::GFP expression is low or
absent in cells expressing high LET-23 EGFR levels and vice versa (Fig. 4 E).
Since the DEP-1::GFP expression pattern is very similar to that of a translational
LIN-12::GFP reporter, we tested if dep-1 transcription is controlled by LIN-12 NOTCH
(Levitan and Greenwald 1998; Shaye and Greenwald 2002). Although the dep-1p::gfp
transcriptional reporter is expressed in ectopic 2° cells of lin-12(gf) mutants, no up-
regulation can be observed when compared to dep-1p::gfp levels in the 2° VPCs of
wild-type animals (Fig. 4 G and H). In lin-12 notch(lf) animals, dep-1p::gfp remains
expressed in P5.p and P7.p descendants at similar level as in wild-type animals (Fig.
4 I, 89% of l in-12(lf) L3 larvae, n=37). In addition, no cluster of CSL sites
characteristic of the known LIN-12 NOTCH targets can be found in regulatory region
of dep-1 (Berset et al. 2001; Yoo et al. 2004). Thus, dep-1 is not a transcriptional
target of the lateral DELTA/NOTCH signaling pathway.
EGFR signaling coordinately down-regulates DEP-1 and LIN-12 NOTCH
expression in the 1° vulval cells
In lin-12(gf) animals, which lack an AC and hence produce no inductive signal
(Greenwald et al. 1983), dep-1p::gfp remains expressed in the P6.p descendants
(Fig. 4 H), suggesting that EGFR/RAS/MAPK signaling down-regulates dep-1
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expression in 1° cells. Supporting this idea, we observed an asymmetric DEP-1::GFP
expression pattern among the 2° vulval cells that is complementary to the pattern of
the EGFR/RAS/MAPK target egl-17 (Burdine et al. 1998). DEP-1::GFP levels are
consistently higher in the proximal 2° cells (P5.ppx and P7.pax) that are in direct
contact with the 1° descendants of P6.p that produce the lateral signal (fig. 4 C and
F). Conversely, EGL-17::GFP expression is higher in the distal 2° cells (P5.pax and
P7.ppx) that probably receive less lateral signal and hence exhibit higher
EGFR/RAS/MAPK pathway activity (data not shown). To test whether
EGFR/RAS/MAPK signaling represses DEP-1 transcription, we examined the DEP-
1::GFP expression pattern in sur-2(lf) animals. sur-2 encodes a component of the
mediator complex that acts downstream of the EGFR/RAS/MAPK pathway to induce
LIN-12 NOTCH down-regulation in 1° cells and activate lateral signaling (Singh and
Han 1995; Shaye and Greenwald 2002; Chen and Greenwald 2004). In sur-2(lf)
mutants, a 1° vulval lineage is frequently induced in P6.p, but no 2° cells are specified
because P6.p produces no DSL ligands (Chen and Greenwald 2004). Similar to LIN-
12::GFP, DEP-1::GFP remains expressed in sur-2(lf) mutants in all or half of the cells
in the 1° lineage (Fig. 4 I and J; 80% of sur-2(lf) animals express DEP-1::GFP in the
1° lineage, compared to 9% in a wild-type background, n=54 and 34, respectively).
Thus, the AC signal simultaneously down-regulates DEP-1 and LIN-12 NOTCH
expression in the 1° vulval cells via the SUR-2 transcription factor (Fig. 6).
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DEP-1 regulates the binary cell fate choice in the excretory system
Finally, we examined whether DEP-1 regulates the specification of the duct cell
fate in the excretory system, which is another example of a binary cell fate decision
controlled by the EGFR/RAS/MAPK pathway (Fig. 5 A) (Yochem et al. 1997). During
embryonic development, one descendant of each the AB.pl and the AB.pr lineage has
the potential to adopt the duct cell fate. In wild-type animals, the AB.pl descendant
differentiates into the duct cell, while the AB.pr descendant adopts the G1 fate. ras
gain-of-function mutants develop two duct cells, whereas ras loss-of-function mutants
form two G1 cells (Fig. 5 A to E). If the EGFR/RAS/MAPK pathway is inactivated in
the AB.pl lineage, then the G1 precursor from the AB.pr lineage generates a duct cell,
indicating that the duct cell or its precursor normally inhibits the G1 precursor from
producing a duct cell (Yochem et al. 1997). dep-1(lf); lip-1(lf) double mutants
frequently display duct cell duplications as shown by the ectopic expression of the lin-
48::gfp marker (Fig. 5 F, G and H) (Sewell et al. 2003). In contrast, pry-1 axin(lf), bar-
1(gf) and lin-12 notch(lf) mutants never have more than one duct cell, and lin-12(gf),
glp-1 notch(gf) and bar-1(lf) mutants always contain a duct cell (Fig. 5 H) (Lambie and
Kimble 1991). Thus, neither the wnt nor the lin-12 notch pathways control duct cell
fate specification. Therefore, dep-1 inhibits EGFR/RAS/MAPK signaling in the G1
precursor independently of the wnt and notch signals.
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Discussion
DEP-1 specifically inhibits LET-23 EGFR signaling
We have identified the R-PTP DEP-1 in a forward genetic screen for genes that
regulate the 1° versus 2° cell fate choice decision during C. elegans vulval
development. Several lines of evidence indicate that DEP-1 specifically inhibits the
transduction of the AC signal by dephosphorylating the EGFR homolog LET-23. First,
LET-23 EGFR is the only RTK known to regulate 1° vulval fate as well as duct cell
specification. In both of these tissues, dep-1(lf) leads to the same phenotype as
increased EGFR/RAS/MAPK signaling. Second, the genetic epistasis analysis
indicates that DEP-1 inhibits 1° fate specification upstream of the adaptor protein
SEM-5 GRB2. In addition, dep-1(lf) in combination with lip-1(lf) renders vulval
induction partially independent from the AC signal, suggesting that in a dep-1(lf)
background the AC-independent activity of LIN-3 EGF (Dutt et al. 2004) becomes
sufficient to induce vulval differentiation. Third, protein interaction experiments show
that the intracellular domain of DEP-1 is sufficient to bind to LET-23, as a substrate-
trapping mutant of DEP-1 but not wild-type DEP-1 captures LET-23 EGFR from total
animal lysates. This observation indicates that DEP-1 specifically binds to
phosphorylated LET-23 via its substrate-binding pocket in the phosphatase domain
(Palka et al. 2003). Fourth, DEP-1::GFP and LET-23 EGFR are co-localized in
intracellular punctae, suggesting that DEP-1 dephosphorylates LET-23 after the
receptor has undergone ligand-induced endocytosis. Similarly, mammalian PTP-1B
interacts with internalized PDGFR and EGFR on the surface of the endoplasmic
reticulum (Haj et al. 2002).
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On the other hand, we do not observe a function of DEP-1 in developmental
processes controlled by other RTKs. For example, dep-1(lf) does not suppress the
Dauer phenotype caused by a reduction-of-function mutation in the daf-2 insulin
receptor, and dep-1(lf) animals do not exhibit the Clear phenotype caused by a
hyperactivation of the egl-15 FGF receptor (data not shown) (Kokel et al. 1998). In
addition, RNAi analysis of 121 of the 165 predicted C. elegans protein phosphatase
genes in a l ip-1(lf) and dep-1(lf)  background has identified no additional
phosphatases that show a genetic interaction with lip-1 or dep-1 (U. Forster and A.
Hajnal, unpublished results). Taken together, these observations point at a relatively
high specificity of DEP-1 for LET-23 EGFR. This specificity may be achieved through
a combination of the intrinsic substrate specificity of the phosphatase domain with a
tightly regulated and dynamic expression pattern that maintains DEP-1 expression in
a subset of cells and a restricted subcellular localization that allows DEP-1 to act only
on internalized LET-23 EGFR.
DEP-1 inhibits 1° cell fate specification in parallel with the LIN-12 NOTCH
pathway
Lateral inhibition mediated by the NOTCH signaling pathway controls binary cell
fate decisions during the development of most if not all animals (for review see Lai
2004). In the developing vulva, LIN-12 NOTCH was found to inhibit 1° cell fate
specification in the future 2° cells by inducing the transcription of a set of inhibitors of
the inductive EGFR/RAS/MAPK pathway (Berset et al. 2001; Yoo et al. 2004).
Although DEP-1::GFP expression is highest in 2° vulval cells, dep-1 is not a direct
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LIN-12 NOTCH target gene. Rather, DEP-1 and LIN-12 NOTCH expression is
simultaneously repressed in P6.p by the inductive EGFR/RAS/MAPK signaling
pathway, which creates a positive feedback loop in the 1° cell lineage (Fig. 6). Similar
to LIN-12 NOTCH, the down-regulation of DEP-1 is mediated by the SUR-2
transcription factor, but unlike LIN-12 NOTCH, which is regulated at the level of
protein stability (Shaye and Greenwald 2002), DEP-1 expression is repressed at the
level of transcription. Since LIN-12 NOTCH signaling inactivates the
EGFR/RAS/MAPK pathway in P5.p and P7.p, DEP-1 expression persists in the 2°
cells. Thus, DEP-1 inhibits LET-23 EGFR signaling in parallel with LIN-12 NOTCH to
ensure a robust inhibition of the 1° fate in P5.p and P7.p and their descendants. This
conclusion is further supported by the finding that dep-1 controls the duct cell fate
decision in the excretory system independently of the NOTCH pathway.
Why is such a complex regulatory network with multiple, genetically redundant inhibitors
required for vulval pattern formation? Beginning in the L2 stage, the AC generates a
gradient of LIN-3 EGF, which causes the activation of the EGFR/RAS/MAPK pathway in
all six VPCs. Even after vulval induction, the AC continues to express LIN-3 throughout
the remaining vulval cell divisions. One explanation is therefore that the NOTCH-
mediated lateral inhibition that begins in the G1 phase of the VPC cell cycle does not
irreversibly inhibit 1° cell fate specification in P5.p and P7.p (Ambros 1999). Indeed, a 2°
cell can still be converted into a 1° cell by increasing the MAPK signal until the G1 phase
of the following cell cycle (Wang and Sternberg 1999 and this study). Thus, the
repression of the EGFR/RAS/MAPK pathway in the 2° cells must be maintained for at
least one more round of cell divisions. DEP-1 expression in the 2° vulval cell lineage may
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be necessary to sustain the effect of lateral inhibition until the daughter cells of P5.p and
P7.p have irreversibly adopted the 2° fate.
Another possible answer lies in the developmental robustness and flexibility of vulval
development that is best observed in ablation experiments. For example, if the future 1°
cell P6.p is removed before vulval induction takes place, then P5.p will adopt the 1°
instead of the 2° fate it normally adopts, and its neighbor P4.p will differentiate into a 2°
cell instead of adopting the 3° fate. Developmental flexibility and robustness may become
even more important in higher organisms, where individual cells must be selected from
much larger groups of precursor cells. It will therefore be interesting to see if DEP-1
performs a similar role during the development of higher organisms.
C. elegans as a model to study tumor suppressor gene function
Our results establish C. elegans as a model to study the function of dep-1 during
development, which may lead to an understanding of the molecular mechanism
underlying the tumor suppressor activity of mammalian Dep-1. Loss of C. elegans
dep-1 function alone does not cause a visible developmental defect, but it shifts the
balance in the uncommitted VPCs from the 2° towards the 1° cell fate. Similarly,
mutations in human Dep-1/Scc1 alone are not sufficient to induce oncogenic
transformation, but they increase the likelihood of tumor development in various
epithelial tissues, especially in the intestinal mucosa (Ruivenkamp et al. 2002). In
analogy to the function of C. elegans DEP-1, the defect leading to the formation of
intestinal carcinomas may be a failure to restrict EGFR-stimulated cell proliferation in
the epithelia. At the base of intestinal crypts, stem cells can either proliferate or
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differentiate into migratory enterocytes that leave the base of the crypts. Possibly,
loss of DEP-1 function shifts this balance, leading to an accumulation of proliferating
undifferentiated cells that may further develop into tumor cells.
Materials and Methods
General C. elegans methods and strains
C. elegans strains were cultured at 20°C as described (Brenner 1974). Wild-type
refers to C. elegans variety Bristol, strain N2. The mutations used are listed below.
Unless noted otherwise, the mutations used have been described (Riddle 2001).
Standard methods were used to construct double and triple mutants. Unless noted in
the table legend, all experiments were conducted at 20°C. dep-1(zh34) was cis-linked
with unc-4(e120) or bli-1(e769) to construct the double mutants shown in table 1. The
induction of VPCs was scored at the L4 larval stage using Nomarski optics as
described (Berset et al. 2001). To ablate the gonad, the nuclei of the Z1 to Z4 gonad
precursor cells were ablated in early L1 larvae with a laser microbeam as described
(Kimble 1981). The operated animals were allowed to develop until the L4 stage
when successfully ablated animals, in which neither gonad arm had developed and
no residual gonadal cells survived, were identified under Nomarski optics.
Alleles used: LGI: lin-10(e1438), unc-13(e1091), unc-101(sy108), sur-2(ku9),
pry-1(mu38) LGII: dep-1(zh34) (this study), lin-7(e1413), unc-4(e120), dpy-10(e128),
bli-1(e769), let-23(sy1), rrf-3(pk1426) (Simmer et al. 2002), LGIII: unc-119(e2498),
dpy-19(e1259), lin-12(n137n720lf), unc-32(e189), lin-12(n137gf), daf-2(e1370). LGIV:
lip-1(zh15) (Berset et al. 2001), let-60(n1046gf), lin-3(e1417), unc-5(e53), ark-
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1(sy247) (Hopper et al. 2000) LGX: sli-1(sy143) (Jongeward et al. 1995), gap-
1(ga133) (Hajnal et al. 1997), lin-15(n309), sem-5(n2019), lin-2(n397), bar-1(ga80)
(Eisenmann et al. 1998).
Transgenic arrays (transgene, co-transformation marker): saIs14[lin-48::gfp,
unc-119(+)] (Sewell et al. 2003), arIs92[egl-17p::cfp-lacZ,unc-4(+)] (Yoo et al. 2004),
gaIs36[HS-mpk-1(+),EF1alpha-D-mek(+)unc-30(+)] V (Lackner and Kim 1998),
zhIs10[dep-1p-Δpes::nls::gfp::lacZ, unc-119(+)] (this study); zhEx112[dep-1::gfp, unc-
119(+)] (this study); zhEx113[dep-1::gfp, lin-48::gfp] (Johnson et al. 2001);
zhEx90[F44G4.8, sur-5::gfp] (this study).
Positional cloning of dep-1
Young adult lip-1(zh15) hermaphrodites were mutagenized with 50 mM Ethyl
Methanesulfonate for 4 hours at room temperature, and the F2 generation was
screened for mutants displaying an Apf phenotype. Approximately 30’000 haploid
genomes were screened. dep-1(zh34); lip-1(zh15) mutants were backcrossed three
times against Bristol N2, and chromosomal linkage of zh34 to LGII was determined by
bulk-segregant analysis as described (Wicks et al. 2001). Three factor mapping
placed dep-1(zh34) between dpy-10 and unc-4, approximately at position 0.9. For
high-resolution SNP mapping, unc4(e120) dep-1(zh34); lip-1(zh15) and dpy-10(e128)
dep-1(zh34); lip-1(zh15) animals were crossed with the polymorphic mapping strain
C. elegans CB4856 (Wicks et al. 2001). Apf nonUnc and Apf nonDpy recombinants
were isolated and F3 clones homozygous for the recombinant chromosome were
established. Informative SNPs were selected from the C. elegans genome
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sequencing centre web site (http://genome.wustl.edu/). SNP analysis defined a region
between snp_F37B12 and snp_T07D4 (fig. 1 P). RNAi analysis (see below) of the 54
of the predicted genes in this region in an rrf-3(pk1426); lip-1(zh15) background
identified F44G4.8 as the candidate gene. Rescue experiments were performed as
follows: 20.6 kb PCR products were amplified with TaKaRa LA Taq (TAKARA BIO
INC) using the primers OTB57 (GGA TTT TGA ACC ATT GGG TCG) and OTB44
(ATG AGC TAC CCG TGG AAA CC) from the cosmid F44G4, pooled and tested for
integrity by restriction enzyme digestion. 30ng/µl of purified PCR product were
injected together with 50 ng/µl of pTG96 (sur-5::gfp) as transformation marker into
wild-type animals, and three independent transgenic lines were crossed to dep-
1(zh34); lip-1(zh15) mutants to assay for rescue.
GFP reporter constructs
For the dep-1p::gfp transcriptional reporter, a 6.1 kb fragment from the 5’ region
of dep-1 was PCR amplified from wild-type genomic DNA with the primers OTB77
(GCA TGC GGA AAG TGA TCG AAT TGA CCG) and OTB76 (GCA TGC GTA GTT
TTT CCG CAA CTC GTG), digested with SphI and cloned into pTB11. pTB11
contains a 370 bp BamHI fragment with a Δpes-10 minimal promoter isolated from
pPD95.21 and inserted into the BamHI site of the nls::gfp::lacZ reporter plasmid
pPD96.04. (All pPD plasmids are gifts of A. Fire.) The translational dep-1::gfp reporter
was constructed as follows: A 5.6 kb genomic PCR fragment that includes 4.5 kb of
the dep-1 upstream region was amplified from wild-type DNA with the primers OTB94
(GTC GAC GGA TTT TGA ACC ATT GGG TCG) and OTB70 (GGT CTA CTA CTC
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ATT CCG TC), digested with SalI and BamHI and cloned into pPD95.75. A second
fragment of 3.7 kb was amplified from dep-1 cDNA with the primers OTB93 (TTT
GCC ATC AAG AAG GAT TCC) and OTB92 (GGA TCC CGA AAT CCC GAT TCG
ACA ATC AT), digested with BamHI and cloned in frame to gfp.
Transgenic animals
Transgenic animals were generated either by microinjection of DNA or by micro-
particle bombardment as described (Mello et al. 1991 ; Praitis et al. 2001). Where
indicated, extrachromosomal arrays were integrated into the genome by gamma-
irradiation of L4 larvae. Integrated arrays were backcrossed at least five times before
further analysis.
GST pull-down experiments
A cDNA fragment encoding the intracellular domain of DEP-1 (amino acids 925 to
1367) was cloned into the BamHI site of the E.coli expression vector pGEX-2TK
(Pharmacia). The D1241 to A mutation was introduced by site-directed mutagenesis using
the Quick-change kit (Stratagene). Recombinant proteins were affinity-purified on
glutathione sepharose beads according to the manufacturers protocol (Pharmacia), except
that protein expression was induced in BL21 bacteria at 25°C, and fusion proteins were
extracted in the presence of 0.1% Triton X100 and 450mM NaCl. Approximately 1 µg of
each DEP-1 fusion protein and 10 µg of GST as negative control were used in each
binding reaction. To prepare N2 worm extracts, mixed-stage cultures were washed 3
times with PBS, resuspended in lysis buffer (25mM Tris pH 7.5, 150 mM NaCl, 0.5%
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Triton X100, 10mM EDTA, 1x protease inhibitor cocktail (Roche)), homogenized with a
douncer and centrifuged for 15 minutes at 4°C and 10000g to remove insoluble
components. About 100µg of total protein extract was used in each reaction. Binding was
performed at room temperature for 2 hours, the sepharose beads were washed 3 times
with lysis buffer, and bound proteins were eluted by boiling the beads for 5 minutes in
SDS gel-loading buffer. LET-23 was detected on Western blots of 10% acrylamide gels
with polyclonal affinity-purified LET-23 antibody (Kaech et al. 1998). Similar results were
obtained using a monoclonal antibody raised against the same LET-23 epitope (data not
shown).
Antibody staining and GFP expression studies
LET-23 antibody staining using a polyclonal antibody against the LET-23 C-
terminus was performed as described in (Kaech et al. 1998). GFP and CFP
expression was observed under fluorescent light illumination with a Leica DMRA
microscope equipped with a cooled CCD camera (Hamamatsu ORCA-ER) controlled
by the Openlab 3.0 software package (Improvision). To score GFP expression in the
Pn.p cells, animals were mounted on 3% agarose pads in M9 solution containing 15
mM NaN3. Larvae were first inspected using Nomarski optics to identify the position of
the Pn.p cells or their descendants, and GFP expression was then scored under
fluorescent light illumination using the same exposure settings for a particular
transgene in all different genetic backgrounds.
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RNAi interference
RNAi was performed by feeding worms with dsRNA-producing E.coli as
described (Kamath et al. 2001) with the following modifications: 5 to 10 L1 larvae
were placed on the RNAi plates, and the P0 and F1 generation were inspected for
Apf phenotypes. 3mM IPTG was added to the agar to induce the expression of
dsRNA.
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Table 1: DEP-1 inhibits LET-23 EGFR signaling
genotype
induced VPCs/
animal1
vulval
phenotype2 n
wild-type 3.0 w.t. many
lip-1(lf) 3.0 w.t. 50
dep-1(lf) 3.0 w.t. 50
dep-1(lf); lip-1(lf) 3.2 75% Apf, 19% Muv 101
lip-1(lf); gfp RNAi3 3.0 wt 20
lip-1(lf); dep-1 RNAi3 3.1 53% Apf, 10% Muv 92
dep-1(lf); lip-1(lf); zhEx90[dep-1(wt)] 4 n.d. 3% Apf 33
dep-1(lf); lip-1(lf); zhEx113[dep-1::gfp] 4 n.d. 13% Apf 23
let-60(gf) 4.2 2% Apf, 70% Muv 43
dep-1(lf);let-60(gf) 5.5 30% Apf, 100% Muv 41
lin-15 (lf) 6 49% Apf, 100% Muv 55
dep-1(lf); lin-15(lf) 6 97% Apf, 100% Muv 57
hs::mpk-1 induced before VPC divisions5 5 100% Apf, 100% Muv 9
hs::mpk-1 induced after VPC divisions5 3.4 50% Apf, 20% Muv 14
lip-1(lf) gonad ablated 0 100% Vul 18
dep-1(lf) gonad ablated 0 100% Vul 16
dep-1(lf); lip-1(lf) gonad ablated 1.0 92% Vul, 4% Apf 24
let-23(rf); gfp RNAi3 0.5 96% Vul 25
let-23(rf); dep-1 RNAi3 1.3* 77% Vul 31
lin-2(lf) 0.3 100% Vul 28
dep-1(lf); lin-2(lf) 2.3*** 44% Vul 27
lin-7(lf) 0.2 100% Vul 24
dep-1(lf); lin-7(lf) 2.5*** 20% Vul 18
lin-10(lf) 0.4 100% Vul 31
lin-10(lf); dep-1(lf) 1.3* 64% Vul 22
sem-5(rf) 0.9 76% Vul 25
dep-1(lf); sem-5(rf) 1.2 75% Vul 24
bar-1(lf) 2.5 30% Vul 43
dep-1(lf); bar-1(lf) 2.5 38% Vul 40
1 Average number of VPCs per animal that have adopted a 1° or 2° vulval fate. 2% Apf: fraction of animals, in
which P5.p and/or P7.p have adopted a 1°-like fate as shown in fig. 1 D scored under Nomarski optics; %
Vul: animals with fewer than 3 induced VPCs; % Muv: animals with more than 3 induced VPCs. *** indicates
a p value ≤0.0001, ** a p value ≤0.001 *a p value ≤0.05. 3RNAi experiments were done in the RNAi
hypersensitive rrf-3(lf) background. 4Young adults were analyzed for their vulva morphology under a
dissecting microscope. Three independent dep-1(wt) lines and one dep-1::gfp line were tested for recue.
5Larvae at the indicated stages were heat-shocked for 30 minutes at 33°C. See the materials and methods
section for details on experimental procedures and alleles used.
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Figure legends
Figure 1. Identification and morphological characterization of dep-1.
(A) Genetic screen to identify Apf mutants. (B) Wild-type vulva in an L4 larva
and (C) adult. (D) Vulva of a dep-1(lf); lip-1(lf) L4 larva. Note that the P5.p and P7.p
descendants have detached from the cuticula and moved inwards (9). (E) Adult dep-
1(lf); lip-1(lf) animal exhibiting a protrusion of vulval tissue due to the Apf phenotype.
(F) and (G) Overexpression of MPK-1 after the first round of VPC cell divisions
causes an Apf phenotype similar to the dep-1(lf); lip-1(lf) L4 larva shown in (D). (H)
let-60 ras(gf) L4 larva. P5.p and P7.p have adopted the 2° fate, and their descendants
remain attached to the cuticula, while some descendants of P4.p form an anterior
pseudovulva (small arrow). (I) Adult let-60(gf) animal with a normal vulva in the centre
(large arrow) and an anterior pseudovulva (small arrow). (J) A dep-1(lf); let-60(gf) L4
larva and (K) adult animal exhibiting an Apf and Muv phenotype. (L) A lin-12 notch(gf)
L4 larva, in which all VPCs have adopted the 2° fate. The orientations of the 2° fates
are indicated with arrows. (M) A dep-1(lf); lin-12(gf); lip-1(lf) triple mutant displaying
an Apf phenotype. (N) % L3 larvae displaying egl-17::cfp expression in P5.px or
P7.px cells. (O) % L3 larvae showing LET-23 expression in P5.p or P7.p descendants
at the Pn.px and Pn.pxx stages. (P) LET-23 antibody staining of a lip-1(lf) and a dep-
1(lf); lip-1(lf) mid-L3 larva at the Pn.pxx stage. MH27 staining of the adherens
junctions in the animals is shown below. Scale bar is 10 µm.
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Figure 2. Positional cloning of dep-1.
(A) Map position, intron-exon structure and fragments used for rescue and RNAi
experiments. (B) Domain structure of DEP-1 (F44G4.8) compared with human DEP-1
and Drosophila Ptp4E. Open boxes represent the fibronectin-binding III repeats and
black boxes the catalytic phosphatase domain. “I” indicates the percent sequence
identity between the catalytic domains. The location of the zh34 stop mutation and the
catalytic centre are highlighted. (C) Dendogram showing the relationship between C.
elegans (C.e.) DEP-1 (F44G4.8) and R-PTPs from Drosophila melanogaster (D.m.)
and Homo sapiens (H.s.) calculated with the neighbor joining method using the
CLUSTAL X algorithm (Thompson et al. 1997). (D) Sequence alignment of the
catalytic phosphatase domains of C. elegans DEP-1 with the catalytic domains of
human class III R-PTPs. The asterisk indicates the position of the stop mutation in
dep-1(zh34) animals, and the catalytic centre containing the essential cysteine
residue is underlined. Genebank accession numbers: C.e. DEP-1 CAA90125, H.s.
DEP-1 Q12913, H.s. R-PTP-H NP002833 , H.s. R-PTPβ P23467, D.m. PTP4E
AAA76834, D.m. PTP10D P35992, H.s. R-PTP-RO AAH35960.
Figure 3. A substrate trapping mutant of DEP-1 binds LET-23 EGFR.
Binding of LET-23 EGFR from N2 worm lysates to GST::DEP-1 fusion proteins
detected on a Western blot with polyclonal LET-23 antibodies (left panel). 20% of the
amount of N2 lysate used in the binding reactions were loaded in the left most lane.
The band around 150 kDa corresponds to full-length LET-23. n.s. indicates a non-
specific cross reacting band since a similar sized band was detected in extracts from
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mammalian cells lacking LET-23 expression. The same amounts of recombinant
proteins use for the binding reactions were loaded on a parallel gel stained with
coomassie blue shown in the right panel. For details on the assay conditions, see
materials and methods.
Figure 4. DEP-1::GFP expression pattern during vulval development.
 (A) to (D) Expression pattern of the translational DEP-1::GFP reporter during
vulval development. Note in (C) the lower levels of DEP::GFP in the two distal cells of
the 2° lineages at the Pn.pxx stage. (E) Mutually exclusive DEP-1::GFP and LET-23
antibody staining at the Pn.pxx stage. (F) Summary of the observed DEP-1::GFP
expression pattern. (G) Expression of the transcriptional dep-1p::gfp reporter in wild-
type, (H) lin-12(gf) and (I) lin-12(lf) larvae at the Pn.pxx and Pn.px stages, respectively.
(J) Persisting DEP-1::GFP expression in all or (K) half of the induced cells in sur-2(lf)
mutants. (L) Subcellular localization of DEP-1::GFP and (M) LET-23 at the Pn.px
stage. (N) Merged image. Arrows point at intracellular punctae containing both DEP-
1::GFP and LET-23. Scale bars in (N) is 5 µm, otherwise 10 µm.
Figure 5. DEP-1 controls duct cell specification.
(A) Lineage relationship between the duct and G1 cells and phenotypes caused
by let-60 ras mutations (adapted from (Yochem et al. 1997)). (B) Nomarski and (C)
GFP fluorescence image of the duct cell in a wild-type L3 larva carrying the LIN-
48::GFP reporter (Sewell et al. 2003). (D) and (E) let-60(gf) larva containing two duct
cells. (F) and (G) dep-1(lf); lip-1(lf) animal exhibiting duct cell duplication. Arrows point
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at the nuclei of LIN-48::GFP expressing cells. Scale bar is 5 µm. (H) Quantification of
the duct cell duplications. n indicates the number of larvae scored for each genotype.
Figure 6. A model for DEP-1 function during vulval development.
The inductive AC signal simultaneously down-regulates LIN-12 NOTCH and
DEP-1 expression in P6.p via SUR-2, while LIN-12 and DEP-1 block the reception and
transduction of the inductive signal in P5.p and P7.p.






